Literature DB >> 25973030

MiRNA profile of osteosarcoma with CD117 and stro-1 expression: miR-1247 functions as an onco-miRNA by targeting MAP3K9.

Fuyou Zhao1, Jie Lv2, Huaiyong Gan3, Yumei Li1, Ri Wang1, Haoran Zhang1, Qiong Wu1, Yuqing Chen4.   

Abstract

microRNAs (miRNA) are regulators of gene expression, but little is known about miRNA expression profiles in stem cells of osteosarcoma (OS). C117 and Stro-1 are known stem cell markers of OS. In the study, CD117 and stro-1 positive (CD117(+)stro-1(+)) and CD117 and stro-1 negative (CD117(-)stro-1(-)) cells were isolated from MG63 cells CD117(+)stro-1(+) cells showed more metastatic ability and stem cell formation rate than CD117(-)stro-1(-) ones. To find the difference between CD117(+)stro-1(+) and CD117(-)stro-1(-) cells, the miRNA expression profile was examined using DNA microarray. MicroRNAs were differentially expressed in osteosarcoma cells with CD117(+)stro-1(+) and CD117(-)stro-1(-). The significant miRNAs included miR-15a, miR-302a, miR-423-5p, miR-1247, miR-1243 and others, which were confirmed by real time RT-PCR. The significant down-regulated miR-1247 was confirmed that was a potential tumor suppressor by targeting MAP3K9. Our results indicated that dysregulation of miRNAs is involved in osteosarcoma and miR-1247 plays an important role in progression of osteosarcoma.

Entities:  

Keywords:  MAP3K9; miR-1247; miRNA profile; osteosarcoma

Mesh:

Substances:

Year:  2015        PMID: 25973030      PMCID: PMC4396303     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  16 in total

Review 1.  MicroRNAs in cancer: biomarkers, functions and therapy.

Authors:  Josie Hayes; Pier Paolo Peruzzi; Sean Lawler
Journal:  Trends Mol Med       Date:  2014-07-12       Impact factor: 11.951

2.  Expression of c-kit in human osteosarcoma and its relevance as a prognostic marker.

Authors:  Irene Sulzbacher; Peter Birner; Cyril Toma; Nikolaus Wick; Peter R Mazal
Journal:  J Clin Pathol       Date:  2006-10-03       Impact factor: 3.411

Review 3.  Osteosarcoma: review of the past, impact on the future. The American experience.

Authors:  Norman Jaffe
Journal:  Cancer Treat Res       Date:  2009

4.  CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance.

Authors:  Amit S Adhikari; Neeraj Agarwal; Byron M Wood; Constance Porretta; Bernardo Ruiz; Radhika R Pochampally; Tomoo Iwakuma
Journal:  Cancer Res       Date:  2010-05-11       Impact factor: 12.701

5.  miRNA expression profile in human osteosarcoma: role of miR-1 and miR-133b in proliferation and cell cycle control.

Authors:  Chiara Novello; Laura Pazzaglia; Chiara Cingolani; Amalia Conti; Irene Quattrini; Maria Cristina Manara; Mauro Tognon; Piero Picci; Maria Serena Benassi
Journal:  Int J Oncol       Date:  2012-11-28       Impact factor: 5.650

Review 6.  Osteosarcoma development and stem cell differentiation.

Authors:  Ni Tang; Wen-Xin Song; Jinyong Luo; Rex C Haydon; Tong-Chuan He
Journal:  Clin Orthop Relat Res       Date:  2008-06-18       Impact factor: 4.176

7.  Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing.

Authors:  Mitchell S Stark; Susan L Woods; Michael G Gartside; Vanessa F Bonazzi; Ken Dutton-Regester; Lauren G Aoude; Donald Chow; Chris Sereduk; Natalie M Niemi; Nanyun Tang; Jonathan J Ellis; Jeffrey Reid; Victoria Zismann; Sonika Tyagi; Donna Muzny; Irene Newsham; YuanQing Wu; Jane M Palmer; Thomas Pollak; David Youngkin; Bradford R Brooks; Catherine Lanagan; Christopher W Schmidt; Bostjan Kobe; Jeffrey P MacKeigan; Hongwei Yin; Kevin M Brown; Richard Gibbs; Jeffrey Trent; Nicholas K Hayward
Journal:  Nat Genet       Date:  2011-12-25       Impact factor: 38.330

Review 8.  MicroRNA function and dysregulation in bone tumors: the evidence to date.

Authors:  Mary Nugent
Journal:  Cancer Manag Res       Date:  2014-01-07       Impact factor: 3.989

Review 9.  Development of microRNA therapeutics is coming of age.

Authors:  Eva van Rooij; Sakari Kauppinen
Journal:  EMBO Mol Med       Date:  2014-07       Impact factor: 12.137

10.  CD271+ osteosarcoma cells display stem-like properties.

Authors:  Jiguang Tian; Xin Li; Meng Si; Ting Liu; Jianmin Li
Journal:  PLoS One       Date:  2014-06-03       Impact factor: 3.240

View more
  20 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  miR-148b-3p, miR-337-5p and miR-423-5p expression in alveolar ridge atrophy and their roles in the proliferation and apoptosis of OMMSCs.

Authors:  Sefei Yang; Jun Guo; Lei Zhou; Helin Xing; Xianli Wang; Chaofang Dong
Journal:  Exp Ther Med       Date:  2018-10-11       Impact factor: 2.447

3.  Inhibition of miR-1247 on cell proliferation and invasion in bladder cancer through its downstream target of RAB36.

Authors:  Yudi Zhu; Shaosi Liang; Huafeng Pan; Zhongliang Cheng; Xin Rui
Journal:  J Biosci       Date:  2018-06       Impact factor: 1.826

4.  MicroRNA-132 inhibits cell growth and metastasis in osteosarcoma cell lines possibly by targeting Sox4.

Authors:  Yulong Liu; Ye Li; Jingchen Liu; Yuntao Wu; Qingsan Zhu
Journal:  Int J Oncol       Date:  2015-09-07       Impact factor: 5.650

Review 5.  Overcoming Therapeutic Resistance of Bone Sarcomas: Overview of the Molecular Mechanisms and Therapeutic Targets for Bone Sarcoma Stem Cells.

Authors:  Tomohiro Fujiwara; Toshifumi Ozaki
Journal:  Stem Cells Int       Date:  2016-12-27       Impact factor: 5.443

6.  Genome-wide miRNA response to anacardic acid in breast cancer cells.

Authors:  David J Schultz; Penn Muluhngwi; Negin Alizadeh-Rad; Madelyn A Green; Eric C Rouchka; Sabine J Waigel; Carolyn M Klinge
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

7.  DNA Methylation Mediated Downregulation of miR-449c Controls Osteosarcoma Cell Cycle Progression by Directly Targeting Oncogene c-Myc.

Authors:  Qing Li; Hua Li; Xueling Zhao; Bing Wang; Lin Zhang; Caiguo Zhang; Fan Zhang
Journal:  Int J Biol Sci       Date:  2017-08-17       Impact factor: 6.580

8.  Silencing of miR-1247 by DNA methylation promoted non-small-cell lung cancer cell invasion and migration by effects of STMN1.

Authors:  Juan Zhang; Jun Fu; Yuliang Pan; Xi Zhang; Liangfang Shen
Journal:  Onco Targets Ther       Date:  2016-12-01       Impact factor: 4.147

9.  Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.

Authors:  Tian Fang; Hongwei Lv; Guishuai Lv; Ting Li; Changzheng Wang; Qin Han; Lexing Yu; Bo Su; Linna Guo; Shanna Huang; Dan Cao; Liang Tang; Shanhua Tang; Mengchao Wu; Wen Yang; Hongyang Wang
Journal:  Nat Commun       Date:  2018-01-15       Impact factor: 14.919

10.  Hsa_circ_0043265 Restrains Cell Proliferation, Migration and Invasion of Tongue Squamous Cell Carcinoma via Targeting the miR-1243/SALL1 Axis.

Authors:  Cuijuan Qian; Yisheng Yang; Tianchen Lan; Yichao Wang; Jun Yao
Journal:  Pathol Oncol Res       Date:  2021-02-03       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.